sigma-tau, Alfasigma Group, is a leading, all Italian capital, international
pharmaceutical company that invests in the research, development and marketing of innovative
and effective treatments to improve human well-being and quality of life.
sigma-tau is present today in the most advanced research sectors, maintaining constant relations with scientific institutions with a world-wide reputation in the development of joint projects and in the implementation of original and innovative research programs.
These results are the fruit of substantial, ongoing investment in research in the field of pharmaceutical innovation and stem not only from the efforts made to produce new products but also from the success of the company’s consolidated products.
Bearing witness to sigma-tau’s achievements are not only the principles and values that inspire our efforts - innovation, dialogue and transparency, ethics, sustainability - but also the facts that have made sigma-tau a leading company in the research, manufacture and marketing of drugs.
In pursuit of its important mission of guaranteeing health and a better quality of life for people world-wide, sigma-tau has constantly combined economic expansion with the creation of value for society and the environment. Research, innovation and business must, in fact, be firmly linked to the social dimension - essential components of an entrepreneurial culture oriented towards responsible, sustainable development, fully respecting the needs of the individual, of society and of the environment.